A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India
NCT05375929
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Abrocitinib 100 mg
DRUG:
Abrocitinib 200 mg
Sponsor
Pfizer